Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.34 |
| ▸ | GPR3 | P46089 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11941221 | 0.86 | GPR3 (0.39) | ALOX5GPR3MAPTALDH1A1RAB9A | |
| SCHEMBL11941219 | 0.82 | TDO2 (0.42) | ALOX5GPR3MAPTRAB9A | |
| SCHEMBL11941218 | 0.80 | HTR2B (0.44) | ALOX5GPR3MAPTALDH1A1HPGD | |
| SCHEMBL11941210 | 0.79 | LIMK1 (0.38) | ALOX5GPR3MAPTALDH1A1HPGD | |
| SCHEMBL11941214 | 0.78 | LIMK1 (0.40) | ALOX5GPR3MAPT | |
| SCHEMBL24795852 | 0.77 | HTR2B (0.45) | ALOX5GPR3MAPTRAB9A | |
| SCHEMBL13021866 | 0.76 | ALOX5 (0.35) | ALOX5GPR3MAPT | |
| SCHEMBL20735557 | 0.75 | ALOX5 (0.41) | ALOX5GPR3MAPTALDH1A1HPGD | |
| SCHEMBL11941220 | 0.75 | GPR3 (0.45) | ALOX5GPR3MAPTALDH1A1HPGD | |
| SCHEMBL11941252 | 0.74 | MEN1 (0.33) | ALOX5MAPTRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8415031-B2 | Electron transporting compounds | UNIVERSAL DISPLAY CORPORATION (US) | 2013-04-09 | — | — | US | disclosed |
| US-8415031-B2 | Electron transporting compounds | UNIVERSAL DISPLAY CORPORATION (US) | 2013-04-09 | — | — | US | disclosed |
| US-20120187381-A1 | Electron Transporting Compounds | UNIVERSAL DISPLAY CORPORATION (US) | 2012-07-26 | — | — | US | disclosed |
| US-20120187381-A1 | Electron Transporting Compounds | UNIVERSAL DISPLAY CORPORATION (US) | 2012-07-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120187381-A1 | Electron Transporting Compounds | SLC19A2, ABCB7, SLCO2B1 | ALOX5 834/4885GPR3 4054/4885MAPT 2243/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.